Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis

European Annals of Allergy and Clinical Immunology

Volumn 38, Issue 10, 2006, Pages 355-360

  Worm, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Asthma; Grass pollen; High dose; Rhinoconjunctivitis; Specific immunotherapy; Sublingual immunotherapy

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; LEVOCABASTINE; LORATADINE; PLACEBO; POLLEN ANTIGEN; SALBUTAMOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GRASS POLLEN; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SCORING SYSTEM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; AREA UNDER CURVE; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PLANT EXTRACTS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 33846461336     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bauchau V., Durham S.-R. - Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J, 2004;24:758-764.
2. Warner J.-O., Kaliner M.-A., Crisci C.-D., Giacco S.-D., Frew A.-J., Liu G.-H. - Allergy practice worldwide: A report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol, 2006;139:166-174.
3. Juniper E.-F. - Quality of life in adults and children with asthma and rhinitis. Allergy, 1997;52:971-977.
4. Li J., Wang H.-Y., Zhang C.-Q., Sun B.-Q., Zhong N.-S. - Links between allergic rhinitis and asthma. Chin Med J, 2006;119:676-683.
5. Bousquet J., Malling H.-J. - WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy, 1998;53:1-42.
6. Möller C., Dreborg S., Ferdousi H.-A., Halken S., Host A., Jacobsen L. et al. - Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109:251-256.
7. Wilson D.-R., Torres Lima M., Durham S.-R. - Sublingual immunotherapy for allergic rhinitis: systemic review and meta-analysis. Allergy, 2005;60:4-12.
8. Dahl R., Stender A., Rak S. - Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy, 2006;61:185-190.
9. Durham S.-R., Yang W.-H., Pedersen M.-R., Johansen N., Rak S. - Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117:802-809.
10. Didier A., Melac M., Combebias A., Andre C. - Efficacy and safety of sublingual immunotherapy [SLIT] tablets in grass pollen rhinoconjunctivitis. J Allergy Clin Immunol, 2006;117:721.
11. Fahlbusch B., Schlenvoigt G., Müller W.-D., Weber B., Jäger L. - A two-site monoclonal antibody ELISA for the quantification of group V allergens in grass extracts. Clin Exp Allergy, 1994;24:752-757.
12. Van Ree R. and CREATE partnership. - The create project: EU Support for the improvement of allergen standardization in Europe. Allergy, 2004;59:571-574.
13. Rolinck-Werninghaus C., Kopp M., Liebke C., Lange J., Wahn U., Niggemann B. - Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen. lnt Arch Allergy Immunol, 2005;136:134-141.
14. Torres Lima M., Wilson D., Pitkin L., Roberts A., Nouri-Aria K., Jacobson M et al. - Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy, 2002;32:507-514.
15. Allam J.-P., Novak N., Fuchs C., Asen S., Berge S., Appel T. et al. - Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol, 2003;112:141-148.
16. Lutz M.-B., Schuler G. - Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol, 2002;169:1810-1816.
17. Akdis C.-A., Barlan I.-B., Bahceciler N., Akdis M. - Immunological mechanisms of sublingual immunotherapy. Allergy, 2006;61:11-14.